Synthesis and anti-H5N1 virus activity of triazole- and oxadiazole-pyrimidine hybrids and their nucleoside analogs.

Clicks: 410
ID: 61227
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #1 of 4 articles by views in nucleosides, nucleotides & nucleic acids

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
New 1,2,3-triazole glycosides and 1,2,4-thioglycosides incorporating a substituted pyrimidinedione ring system were synthesized via click dipolar cycloaddition and heterocyclization of hydrazine-1-carbodithioate derivatives, respectively. The sugar hydrazine derivatives linked aminodimethyluracil were also prepared. In addition, the oxadiazoline substituted with acyclic sugar moieties linked to the pyrimidinedione as acyclic nucleoside analogs were synthesized. The antiviral activity of the synthesized compounds against avian influenza H5N1 virus was investigated and compounds , and showed good activities against the virus strains.
Reference Key
tolan2019synthesisnucleosides Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tolan, Hala E M;El-Sayed, Wael A;Tawfek, Nashwa;Abdel-Megeid, Farouk M E;Kutkat, Omnya M;
Journal nucleosides, nucleotides & nucleic acids
Year 2019
DOI
10.1080/15257770.2019.1674331
URL
Keywords
glycosides triazoles influenza h5n1 pyrimidinedione nucleosides oxadiazole

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.